Global Psoriasis Market 2022-31 : Industry Analysis, Size, Share, Growth and Forecast | AbbVie Inc., Pfizer Inc., Novartis, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc.

Spread the love

The Psoriasis Global Market Report 2021-31 by The Business Research Company describes and explains the global psoriasis market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The Psoriasis Global Market Report 2022 covers psoriasis market drivers, psoriasis market trends, psoriasis market segments, psoriasis market growth rate, psoriasis market major players, and psoriasis market size.

View Complete Report:

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

The psoriasis market report provides in-depth analysis of the impact of COVID-19 on the global psoriasis industry along with revised market numbers due to the effects of the coronavirus and the expected psoriasis market growth numbers for 2022-2031.

The global psoriasis market size is expected to grow from $17.67 billion in 2021 to $19.98 billion in 2022 at a compound annual growth rate (CAGR) of 13.1%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global psoriasis market share is expected to reach $30.90 billion in 2026 at a CAGR of 11.5%.

Request Report Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Psoriasis Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

TBRC’s report covers the psoriasis market segments-
1) By Drug Class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor

2) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

3) By Drug Type: Small Molecules, Biologics

4) By Route of Administration: Oral, Tropical, Injectable

5) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis

Top 5 Major Key Players Are:

Table Of Contents

  1. Executive Summary
  2. Psoriasis Drugs Market Characteristics
  3. Psoriasis Drugs Market Trends And Strategies
  4. Impact Of COVID-19 On Psoriasis Drugs
  5. Psoriasis Drugs Market Size And Growth

.

  1. Psoriasis Drugs Market Competitive Landscape And Company Profiles
  2. Key Mergers And Acquisitions In The Psoriasis Drugs Market
  3. Psoriasis Drugs Market Future Outlook and Potential Analysis
  4. Appendix

List Of Tables

Table 1: Global Historic Market Growth, 2016-2021, $ Billion

Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion

Table 3: Global Psoriasis Drugs Market, Segmentation  By Drug class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 4: Global Psoriasis Drugs Market, Segmentation  By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 5: Global Psoriasis Drugs Market, Segmentation  By Drug Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

,

Table 48: AbbVie Inc. Financial Performance

Table 49: Pfizer Inc. Financial Performance

Table 50: Novartis Financial Performance

Table 51: Eli Lilly and Company. Financial Performance

Table 52: Celgene Corporation Financial Performance

List Of Related Reports

Skin Cancer Drugs Global Market Report 2022

Antifungals Global Market Report 2022

Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022

About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Find us on

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany/

Blog: http://blog.tbrc.info/


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →